Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-25 @ 9:34 PM
NCT ID:
NCT02864251
Group ID:
EG001
Title:
Arm B: Nivolumab Plus Ipilimumab
Description:
Nivolumab 3 mg/kg IV was administered every 2 weeks and ipilimumab 1 mg/kg IV was administered every 6 weeks until the progression of disease, discontinuation due to toxicity, withdrawal of consent, a maximum of 24 months (96 weeks) from the first study treatment, or study closure.
Deaths Number Affected:
55
Deaths Number At Risk:
None
Serious Number Affected:
46
Serious Number At Risk:
71
Other Number Affected:
62
Other Number At Risk:
71
Study:
NCT02864251
Results Section:
NCT02864251
Adverse Events Module:
NCT02864251